
Transcath Therapeutics LLP
About Transcath Therapeutics LLP
Data last updated:
Transcath Therapeutics LLP is a limited liability partnership (LLP) based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAF-8674. The LLP has 1 GST registration on record, which is no longer active.
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners Parth Rajesh Vaishnav and Rajesh Laljibhai Vaishnav.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Surat, Gujarat.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 54/2 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Transcath Therapeutics LLP FY 2024 filings available
Financial Statement Summary of Transcath Therapeutics LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Transcath Therapeutics LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Transcath Therapeutics are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Transcath Therapeutics LLP
Transcath Therapeutics has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parth Rajesh Vaishnav Also directs: Nano Therapeutics Private Limited | Designated Partner | 07 Mar 2016 | 10 Years 7 Months | Current |
| Rajesh Laljibhai Vaishnav Also directs: Nano Therapeutics Private Limited | Designated Partner | 07 Mar 2016 | 10 Years 7 Months | Current |
Charges & Borrowings of Transcath Therapeutics LLP
Transcath Therapeutics LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Transcath Therapeutics LLP
Employment history and EPFO contributions of people linked to Transcath Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Transcath Therapeutics LLP
Transcath Therapeutics LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Parth Rajesh Vaishnav was appointed as Designated Partner on 07 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Transcath Therapeutics LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Transcath Therapeutics LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Transcath Therapeutics LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Transcath Therapeutics LLP
Transcath Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Transcath Therapeutics LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transcath Therapeutics LLP
Transcath Therapeutics is an active limited liability partnership based in Surat, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 2016 (10+ years old) and is registered under LLPIN AAF-8674.
Transcath Therapeutics has 2 current designated partners:
- Parth Rajesh Vaishnav - Designated Partner
- Rajesh Laljibhai Vaishnav - Designated Partner
No. Transcath Therapeutics has 1 GST registration on record and it is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Transcath Therapeutics is AAF-8674. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Transcath Therapeutics was incorporated on 07 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Parth Rajesh Vaishnav was appointed as Designated Partner on 07 Mar 2016. Rajesh Laljibhai Vaishnav was appointed as Designated Partner on 07 Mar 2016.
The registered office of Transcath Therapeutics is at D – 542 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230.
The total obligation of contribution is ₹5 Lakh.
Transcath Therapeutics operates in the pharma industry, in the drug formulation and development segment.
Transcath Therapeutics can be reached at its registered office: D – 542 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230.